PREFERRED STOCK PURCHASE AGREEMENT
New Mexico, US

Agreement date: [date]

Company: [New Mexico corporation name], a New Mexico corporation, of [address] (Company).

Investor: [legal name and entity type], of [address] (Investor).

1. Purchase and sale

At the Closing, Company shall issue and sell to Investor, and Investor shall purchase, [number] shares of Company's [series] preferred stock (Shares) for USD [price] per Share, totaling USD [purchase price] (Purchase Price). The Shares must be part of an existing series duly authorized in Company's articles of incorporation or an effective amendment identified in Schedule 1. This agreement does not itself create or amend a series of stock.

The Shares have only the voting, dividend, liquidation, conversion, redemption and other rights stated in the filed articles and Schedule 1. If Schedule 1 conflicts with the filed articles, the filed articles control.

2. Closing

Closing occurs on [date] by electronic exchange unless the parties agree otherwise. Investor shall deliver the Purchase Price by [wire instructions]. Company shall deliver evidence that the Shares are entered in its stock ledger in Investor's name and, if certificates are used, a certificate bearing the required legends.

Company's obligations are conditioned on receipt of the Purchase Price and Investor's signed representations. Investor's obligations are conditioned on delivery of: (a) board resolutions approving the issue and finding the consideration adequate; (b) a certified copy of the effective articles and amendments authorizing the series and enough unissued Shares; (c) evidence of Company's good standing; and (d) the disclosure materials listed in Schedule 2. A condition may be waived only in writing by the party it protects, and no waiver cures an unlawful issuance.

3. Company representations

Company represents at signing and Closing that:

(a) it is duly incorporated, validly existing and in good standing under New Mexico law and has authority to enter this agreement;

(b) its board has duly approved this agreement, the issuance and the consideration, and no further corporate approval is required except an approval identified in Schedule 1;

(c) the filed articles authorize the series, the number of authorized but unissued shares is sufficient, and the rights in Schedule 1 accurately summarize the filed terms;

(d) when issued against payment, the Shares will be validly issued, fully paid and nonassessable, free of any Company-created lien other than transfer restrictions disclosed here;

(e) execution and performance do not violate its governing documents, a material agreement listed in Schedule 2, or a binding order; and

(f) the capitalization table and material Company disclosures in Schedule 2 are accurate in all material respects as of their stated dates and do not knowingly omit a fact necessary to make them misleading.

4. Investor representations

Investor represents at signing and Closing that Investor has authority to enter this agreement, is acquiring the Shares for Investor's own account for investment and not with a present plan to distribute them unlawfully, and has had access to the information and opportunity to ask questions reasonably needed to evaluate the investment.

Investor understands that the Shares have not been registered under the Securities Act of 1933 or state securities law, may be sold only under an effective registration or an available exemption, may be illiquid, and involve risk of complete loss. Investor shall complete the eligibility information in Schedule 3, including accredited-investor status if the selected exemption requires it. These acknowledgments do not waive fraud claims or Company's disclosure duties.

5. Securities-law compliance and restrictions

Company is responsible for determining and documenting the federal and state exemption relied on, making required notices and filings, and not accepting the Purchase Price if the offering cannot lawfully close. Investor shall provide accurate eligibility and residency information reasonably requested for those filings.

The stock ledger and any certificate shall state the applicable transfer restrictions. Investor shall not transfer Shares unless Company reasonably determines, based on evidence it may request, that the transfer is registered or exempt and complies with the articles and any valid transfer agreement identified in Schedule 1. Company may place a stop-transfer instruction consistent with those restrictions, but may not unreasonably delay a lawful transfer.

6. Company covenants

Company shall apply the proceeds for [working capital and lawful corporate purposes / specific use]. It shall maintain an accurate stock ledger, furnish notices and information required by the filed terms of the series, and reserve shares required for any valid conversion right. Nothing here promises dividends, redemption, conversion, a future financing, a market, tax treatment, or business results beyond the filed terms.

7. Indemnity and remedies

Each party shall indemnify the other from direct loss arising from that party's material breach of a representation, covenant or obligation in this agreement. The claimant shall give prompt notice and reasonable cooperation; delay reduces liability only to the extent it causes prejudice. Neither party is liable for consequential or punitive damages, except for fraud, willful misconduct, unlawful securities distribution, or liability that cannot lawfully be limited.

If Closing fails because a condition is unsatisfied, neither party must close and Company shall promptly return any Purchase Price received, without limiting a claim for prior breach. The parties acknowledge that damages may be inadequate for a breach involving issuance, transfer restrictions or confidentiality, so lawful equitable relief remains available.

8. Confidentiality and announcements

Investor shall protect nonpublic Company information using reasonable care and use it only to evaluate, hold or lawfully transfer the Shares, except for disclosure to bound advisers or as law requires. Company may disclose Investor information as required for corporate records, tax reporting, securities compliance or a lawful request. A public announcement naming the other party requires consent unless legally required.

9. General terms

New Mexico law governs, without displacing applicable federal securities law. State and federal courts in [county], New Mexico have jurisdiction. Notices must be written and sent by personal delivery, tracked delivery or acknowledged email to the addresses above. This agreement, its completed schedules, the filed articles and any agreement identified in Schedule 1 are the entire agreement concerning this purchase. An amendment or waiver must be signed by Company and Investor and cannot amend the articles without the filing and approvals required by law. Neither party may assign this agreement before Closing without consent. Invalid language is narrowed or severed. Counterparts and electronic signatures are permitted, but corporate filings must use the method accepted by the filing office.

SCHEDULE 1 — SHARES AND CORPORATE AUTHORITY

Series, number of Shares, price per Share, and Purchase Price: [details].

Filed articles or amendment authorizing series, filing date and instrument number: [details].

Summary of voting, dividend, liquidation, conversion, redemption and transfer terms: [details].

Board resolutions, required shareholder approval, and other transfer agreement: [details or none].

SCHEDULE 2 — COMPANY DISCLOSURES

Capitalization table; financial statements; material liabilities, litigation, intellectual-property, tax and regulatory matters; conflicting agreements; use of proceeds: [documents and exceptions].

SCHEDULE 3 — INVESTOR ELIGIBILITY

Investor legal form, jurisdiction, address and tax ID: [details].

Applicable exemption and Investor qualification, including accredited-investor category if required: [details].

Investment experience, information received and advisers: [details].

COMPANY
Signature: ____________________ Date: __________
Name and title: [name and title]

INVESTOR
Signature: ____________________ Date: __________
Name and title: [name and title]


---
License: Licensed under CC BY 4.0. Attribution is required when you publish or redistribute this Template or an adapted version to the public. Attribution is not required merely because you use or adapt the Template for your own business or legal purposes, including preparing, negotiating, signing, or exchanging an agreement with a counterparty. License details.
License details: https://contract-templates.getfebruary.ai/license/